These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20300881)

  • 1. Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines.
    Krammer F; Schinko T; Palmberger D; Tauer C; Messner P; Grabherr R
    Mol Biotechnol; 2010 Jul; 45(3):226-34. PubMed ID: 20300881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2.
    Zak AJ; Hill BD; Rizvi SM; Smith MR; Yang M; Wen F
    ACS Synth Biol; 2019 Oct; 8(10):2303-2314. PubMed ID: 31487465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.
    Krammer F; Nakowitsch S; Messner P; Palmberger D; Ferko B; Grabherr R
    Biotechnol J; 2010 Jan; 5(1):17-23. PubMed ID: 20041443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.
    Sequeira DP; Correia R; Carrondo MJT; Roldão A; Teixeira AP; Alves PM
    Vaccine; 2018 May; 36(22):3112-3123. PubMed ID: 28291648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens.
    Choi JG; Kim MC; Kang HM; Kim KI; Lee KJ; Park CK; Kwon JH; Kim JH; Lee YJ
    Vet Microbiol; 2013 Mar; 162(2-4):623-630. PubMed ID: 23265240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Nerome K; Matsuda S; Maegawa K; Sugita S; Kuroda K; Kawasaki K; Nerome R
    Vaccine; 2017 Feb; 35(5):738-746. PubMed ID: 28065477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.
    Thompson CM; Petiot E; Mullick A; Aucoin MG; Henry O; Kamen AA
    BMC Biotechnol; 2015 May; 15():31. PubMed ID: 25981500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
    Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.
    Bright RA; Carter DM; Crevar CJ; Toapanta FR; Steckbeck JD; Cole KS; Kumar NM; Pushko P; Smith G; Tumpey TM; Ross TM
    PLoS One; 2008 Jan; 3(1):e1501. PubMed ID: 18231588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Japanese encephalitis virus-like particles using the baculovirus-insect cell system.
    Yamaji H; Segawa M; Nakamura M; Katsuda T; Kuwahara M; Konishi E
    J Biosci Bioeng; 2012 Dec; 114(6):657-62. PubMed ID: 22841798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
    Quan FS; Huang C; Compans RW; Kang SM
    J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Buffin S; Peubez I; Barrière F; Nicolaï MC; Tapia T; Dhir V; Forma E; Sève N; Legastelois I
    Vaccine; 2019 Oct; 37(46):6857-6867. PubMed ID: 31590935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
    Pushko P; Tumpey TM; Bu F; Knell J; Robinson R; Smith G
    Vaccine; 2005 Dec; 23(50):5751-9. PubMed ID: 16143432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.
    Prel A; Le Gall-Reculé G; Jestin V
    Avian Pathol; 2008 Oct; 37(5):513-20. PubMed ID: 18798027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.
    Wen Z; Ye L; Gao Y; Pan L; Dong K; Bu Z; Compans RW; Yang C
    Antiviral Res; 2009 Dec; 84(3):215-24. PubMed ID: 19772876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.